Emergence of a BCR::ABL1 rearrangement following a uniquely complex clonal evolution pattern in a patient undergoing Fms-like tyrosine kinase 3 inhibitor therapy for acute myeloid leukemia.
Bosung ParkJiyeon KimMiyoung KimYoung-Uk ChoSang-Hyun HwangSeongsoo JangEul-Ju SeoEun-Ji ChoiChan-Jeoung ParkPublished in: International journal of laboratory hematology (2022)